mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.1 |
0.2 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.2 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.2 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.2 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.2 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.2 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.2 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |